Incidence, Trends, and Survival of Children With Embryonal Tumors
- 1 September 2015
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 136 (3) , e623-e632
Abstract
BACKGROUND: Central nervous system (CNS) and non-CNS embryonal tumors occur principally in children and are rarely seen in adults. The incidence rates for rare entities such as atypical teratoid/rhabdoid tumors (AT/RT) or primitive neuroectodermal tumors in the CNS are rarely published. Incidence rates for certain subgroups, such as hepatoblastomas, have been increasing in some countries. METHODS: Data of 8337 embryonal tumors, registered in children (0–14 years) between 1991 and 2012 (for AT/RT 2000–2012) in the population-based German Childhood Cancer Registry with complete national coverage were analyzed for incidence rates, time trends, and survival. RESULTS: For most entities, the incidence rates were the highest for children CONCLUSIONS: This study presents a comprehensive overview of pediatric embryonal tumors from a well-established, complete nationwide cancer registry. Significant increasing trend for hepatoblastomas was detected for the first time in Europe.Keywords
This publication has 47 references indexed in Scilit:
- Predictors of survival and incidence of hepatoblastoma in the paediatric populationHPB, 2013
- National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implicationsThe Lancet, 2012
- Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology GroupHuman Reproduction, 2012
- Trends in incidence of childhood cancer in Australia, 1983–2006British Journal of Cancer, 2010
- Wilmsʼ tumorCurrent Opinion in Pediatrics, 2009
- Trends in childhood cancer incidence in the U.S. (1992–2004)Cancer, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trialThe Lancet, 2004
- Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982–1992European Journal of Cancer, 2000
- Association between hepatoblastoma and very low birth weight: A trend or a chance?The Journal of Pediatrics, 1997